CY1122457T1 - Μη πτητικες οφθαλμικες συνθεσεις, ειδικες για τη θεραπεια της ξηροφθαλμιας - Google Patents
Μη πτητικες οφθαλμικες συνθεσεις, ειδικες για τη θεραπεια της ξηροφθαλμιαςInfo
- Publication number
- CY1122457T1 CY1122457T1 CY20201100004T CY201100004T CY1122457T1 CY 1122457 T1 CY1122457 T1 CY 1122457T1 CY 20201100004 T CY20201100004 T CY 20201100004T CY 201100004 T CY201100004 T CY 201100004T CY 1122457 T1 CY1122457 T1 CY 1122457T1
- Authority
- CY
- Cyprus
- Prior art keywords
- treatment
- dry eye
- volatile
- specific
- ophthalmic compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Η παρούσα ευρεσιτεχνία αφορά σε μία οφθαλμική σύνθεση που περιέχει ένα λιπαντικό πολυμερές και έναν ολιγοσακχαρίτη, καθώς και την τοπική χρήση της, ειδικότερα για την θεραπεία της ξηροφθαλμίας.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1451662A FR3018045B1 (fr) | 2014-02-28 | 2014-02-28 | Composition ophtalmique remanente, notamment pour le traitement de la secheresse oculaire |
PCT/FR2015/050499 WO2015136186A1 (fr) | 2014-02-28 | 2015-03-02 | Composition ophtalmique rémanente, notamment pour le traitement de la sécheresse oculaire |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1122457T1 true CY1122457T1 (el) | 2021-01-27 |
Family
ID=50624806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20201100004T CY1122457T1 (el) | 2014-02-28 | 2020-01-07 | Μη πτητικες οφθαλμικες συνθεσεις, ειδικες για τη θεραπεια της ξηροφθαλμιας |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP3110425B1 (el) |
CY (1) | CY1122457T1 (el) |
DK (1) | DK3110425T3 (el) |
ES (1) | ES2760523T3 (el) |
FR (1) | FR3018045B1 (el) |
HR (1) | HRP20192142T1 (el) |
HU (1) | HUE047396T2 (el) |
LT (1) | LT3110425T (el) |
PL (1) | PL3110425T3 (el) |
PT (1) | PT3110425T (el) |
RS (1) | RS59721B1 (el) |
SI (1) | SI3110425T1 (el) |
WO (1) | WO2015136186A1 (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT202000008299A1 (it) * | 2020-04-17 | 2021-10-17 | Glycores 2000 Srl | Composizione liquida oftalmica comprendente acido ialuronico lineare a basso peso molecolare |
EP4039248A1 (en) * | 2021-02-04 | 2022-08-10 | Warszawskie Zaklady Farmaceutyczne Polfa S.A. | Ophthalmic composition |
EP4218717A1 (en) | 2022-02-01 | 2023-08-02 | Laboratoires THEA | Ophthalmic composition comprising resveratrol for treating dry eye syndrome |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004262777A (ja) * | 2003-02-27 | 2004-09-24 | Shiseido Co Ltd | アセチル化ヒアルロン酸含有眼用医薬組成物 |
CN1302812C (zh) * | 2004-11-30 | 2007-03-07 | 中国海洋大学 | 含海藻糖和玻璃酸的眼部用药传递系统及其制备方法 |
TWI393567B (zh) * | 2005-03-31 | 2013-04-21 | Bausch & Lomb | 治療乾眼之組合物及相關之製造方法及使用方法 |
US20080095754A1 (en) * | 2006-10-18 | 2008-04-24 | Burke Susan E | Ophthalmic compositions comprising diglycine |
MX2009005644A (es) * | 2006-12-22 | 2009-06-08 | Sigma Tau Ind Farmaceuti | Gel util para el suministro de farmacos oftalmicos. |
CN101691478A (zh) * | 2009-09-25 | 2010-04-07 | 海昌隐形眼镜有限公司 | 含海藻糖的角膜接触镜护理组合物及其制备方法 |
CN101691479B (zh) * | 2009-09-25 | 2013-01-16 | 海昌隐形眼镜有限公司 | 一种角膜接触镜保存液组合物及其制备方法 |
US20110319502A1 (en) * | 2010-06-25 | 2011-12-29 | Coffey Martin J | Compositions and Methods for Enhancing Reduction of Spore-Forming Microorganisms |
GB201017048D0 (en) * | 2010-10-08 | 2010-11-24 | Ucl Business Plc | Composition |
-
2014
- 2014-02-28 FR FR1451662A patent/FR3018045B1/fr active Active
-
2015
- 2015-03-02 PL PL15713215T patent/PL3110425T3/pl unknown
- 2015-03-02 LT LT15713215T patent/LT3110425T/lt unknown
- 2015-03-02 HU HUE15713215A patent/HUE047396T2/hu unknown
- 2015-03-02 ES ES15713215T patent/ES2760523T3/es active Active
- 2015-03-02 PT PT157132150T patent/PT3110425T/pt unknown
- 2015-03-02 RS RS20191561A patent/RS59721B1/sr unknown
- 2015-03-02 WO PCT/FR2015/050499 patent/WO2015136186A1/fr active Application Filing
- 2015-03-02 EP EP15713215.0A patent/EP3110425B1/fr active Active
- 2015-03-02 SI SI201531017T patent/SI3110425T1/sl unknown
- 2015-03-02 DK DK15713215T patent/DK3110425T3/da active
-
2019
- 2019-11-28 HR HRP20192142TT patent/HRP20192142T1/hr unknown
-
2020
- 2020-01-07 CY CY20201100004T patent/CY1122457T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP3110425B1 (fr) | 2019-11-13 |
WO2015136186A1 (fr) | 2015-09-17 |
RS59721B1 (sr) | 2020-01-31 |
DK3110425T3 (da) | 2019-12-09 |
SI3110425T1 (sl) | 2020-01-31 |
ES2760523T3 (es) | 2020-05-14 |
FR3018045A1 (fr) | 2015-09-04 |
HRP20192142T1 (hr) | 2020-02-21 |
PL3110425T3 (pl) | 2020-03-31 |
FR3018045B1 (fr) | 2017-06-16 |
EP3110425A1 (fr) | 2017-01-04 |
PT3110425T (pt) | 2019-12-11 |
HUE047396T2 (hu) | 2020-04-28 |
LT3110425T (lt) | 2019-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112019006160A2 (pt) | composições e métodos para o tratamento das condições oftálmicas | |
CY1124215T1 (el) | Μκ2 αναστολεις και χρησεις αυτων | |
AR102657A1 (es) | Composición para tratar telas | |
EA201890204A1 (ru) | Антибактериальные соединения | |
EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
EA201790434A1 (ru) | Модуляторы каналов | |
EA201591137A1 (ru) | Ингибиторы mk2 и их применения | |
BR112014021104A2 (pt) | métodos e composições para o tratamento da doença de huntington | |
EA201591743A8 (ru) | СТИМУЛЯТОРЫ sGC | |
BR112015029686A2 (pt) | composições para o tratamento de superfícies compreendendo corantes fotocrômicos | |
BR112017000024A2 (pt) | composição para tratamento de tecidos que compreende uma nanoemulsão polimérica de aminossiloxano | |
DK3513809T3 (da) | Medicinsk sammensætning, som omfatter tivozanib | |
EA201692526A1 (ru) | Замещенные [1,2,4]триазольные соединения | |
BR102015017380A2 (pt) | dispositivo para a reticulação do tecido do olho, e, composição farmacêutica | |
EA201690613A1 (ru) | Улучшенные составы на основе аденовирусов | |
CY1123194T1 (el) | Νεες αντιβακτηριακες ενωσεις | |
BR112017010177A2 (pt) | composição para tratamento de tecido | |
BR112016017112A2 (pt) | Composições de apilimod e métodos de uso das mesmas | |
CL2015002897A1 (es) | Inhibidores de bace1 | |
TR201910057T4 (tr) | Kauçuk bi̇leşi̇mleri̇ | |
EA201791174A1 (ru) | Антимикотическое соединение | |
CY1122457T1 (el) | Μη πτητικες οφθαλμικες συνθεσεις, ειδικες για τη θεραπεια της ξηροφθαλμιας | |
BR112017009000A2 (pt) | apilimod para uso no tratamento de melanoma | |
BR112018009745A2 (pt) | compostos heterocíclicos para o tratamento de doença | |
TR201820050T4 (tr) | Bromodomain inhibitörleri olarak tetrahidrokinolin türevleri. |